David Hui
M.D. Anderson Cancer Center · Chinese University of Hong Kong · Albert Einstein Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Hui as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:45 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07674797 · Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)M.D. Anderson Cancer Center · not yet recruiting · Oncologic, Palliative Care, Remote Monitoring · principal investigator
- N/ANCT07408310 · Trial of Spiritual Care Interventions for Patients With CancerWeill Medical College of Cornell University · recruiting · Advanced Cancer · principal investigator
- N/ANCT07009886 · Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic TherapyM.D. Anderson Cancer Center · recruiting · Advanced Cancer · principal investigator
- N/ANCT06722846 · Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.M.D. Anderson Cancer Center · recruiting · Health Options, Strategic Care Planning · principal investigator
- Ph2NCT06336642 · Structured Personalized Oxygen and Supportive Therapies for Dyspnea in OncologyM.D. Anderson Cancer Center · recruiting · Dyspnea · principal investigator
- N/ANCT05825014 · Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong KongChinese University of Hong Kong · recruiting · COPD Exacerbation · study director
- Ph2/Ph3NCT05431595 · Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing StrategyM.D. Anderson Cancer Center · recruiting · Delirium, Epileptics, Neuroleptics · principal investigator
- N/ANCT05351515 · Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient ElastographyChinese University of Hong Kong · completed · Sleep Apnea, Obstructive, Fatty Liver · study chair
- Ph4NCT05228418 · Bridging ED to Outpatient AUD Therapy With NaltrexoneAlbert Einstein Healthcare Network · unknown · Alcohol Use Disorder · principal investigator
- N/ANCT05095948 · Improving Processes of Cancer Care Delivery at a Comprehensive Cancer CenterM.D. Anderson Cancer Center · not yet recruiting · Metastatic Malignant Solid Neoplasm · principal investigator
- N/ANCT05091632 · Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care UnitM.D. Anderson Cancer Center · suspended · Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm · principal investigator
- N/ANCT05058339 · Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced CancerM.D. Anderson Cancer Center · completed · Advanced Malignant Solid Neoplasm, COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm · principal investigator
- N/ANCT04989556 · Technology-Enhanced Palliative Care for Advanced Cancer PatientsM.D. Anderson Cancer Center · active not recruiting · Advanced Malignant Solid Neoplasm · principal investigator
- Ph3NCT04188418 · Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer PatientsM.D. Anderson Cancer Center · active not recruiting · Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm · principal investigator
- N/ANCT04125316 · Level of FeNO in Chinese Asthma PatientsChinese University of Hong Kong · completed · Asthma · study director
- Ph1NCT03943797 · Cultivated Autologous Oral Mucosal Epithelial TransplantationChang Gung Memorial Hospital · unknown · Limbal Stem Cell Deficiency · principal investigator
- Ph2/Ph3NCT03743649 · Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative CareM.D. Anderson Cancer Center · active not recruiting · Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm · principal investigator
- Ph2NCT03367156 · Dexamethasone in Controlling Dyspnea in Patients With CancerM.D. Anderson Cancer Center · active not recruiting · Dyspnea, Malignant Neoplasm · principal investigator
- N/ANCT03043378 · Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care ClinicM.D. Anderson Cancer Center · completed · Malignant Neoplasms of Independent (Primary) Multiple Sites · principal investigator
- Ph2/Ph3NCT03040726 · Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With CancerM.D. Anderson Cancer Center · completed · Malignant Neoplasm, Nausea, Vomiting · principal investigator
- Ph2/Ph3NCT03021486 · Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent CancerM.D. Anderson Cancer Center · active not recruiting · Advanced Malignant Neoplasm, Delirium, Locally Advanced Malignant Neoplasm · principal investigator
- Ph2NCT02932332 · High-Flow Oxygen for Dyspnea in Hospitalized Cancer PatientsM.D. Anderson Cancer Center · completed · Cancer · study chair
- Ph2/Ph3NCT02597478 · Fentanyl Sublingual Spray for Exercise-Induced Breakthrough DyspneaM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph2NCT02357134 · High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With CancerM.D. Anderson Cancer Center · unknown · Dyspnea, Malignant Neoplasm · principal investigator
- Ph2NCT01949662 · Haloperidol and Lorazepam for Delirium in Patients With Advanced CancerM.D. Anderson Cancer Center · active not recruiting · Advanced Cancers · principal investigator
- Ph2NCT01856114 · Fentanyl Buccal Tablets for Exercise Induced Breakthrough DyspneaM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- Ph2NCT01832402 · Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough DyspneaM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
- N/ANCT01828216 · Ambulatory Versus Conventional Approach Diagnosing OSAChinese University of Hong Kong · completed · OSA · principal investigator
- Ph2NCT01670097 · Dexamethasone Dyspnea StudyM.D. Anderson Cancer Center · completed · Advanced Cancers, Hematologic Disorder, Solid Tumors · principal investigator
- Ph2NCT01518140 · BiPAP-Vapotherm RCTM.D. Anderson Cancer Center · withdrawn · Advanced Cancers · principal investigator
- Ph1/Ph2NCT01515566 · Breakthrough Dyspnea Fentanyl Study in Cancer PatientsM.D. Anderson Cancer Center · completed · Advanced Cancers, Dyspnea · principal investigator
- Ph2NCT00934128 · High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced CancerM.D. Anderson Cancer Center · completed · Advanced Cancers · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 29 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Oncologic Timely Palliative Care and Remote Monitoring with Electronic Assessments and Telehealth (ON-TARGET)R01CA311058 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2026 · $677,379 awarded in 2026Same name and institution; not confirmed by an ID
- Strategies for Personalizing Oxygen and support Therapies for dyspnea in OncologyR01CA288515 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2024 to 2026 · $161,861 awarded in 2026Same name and institution; not confirmed by an ID
- Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer PatientsR01CA231471 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2020 to 2024 · $110,523 awarded in 2024Grant number is on one of their registry trials
- Strategies for Persistent Agitated Delirium in Palliative CareR01CA225701 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2019 to 2022 · $434,388 awarded in 2022Same name and institution; not confirmed by an ID
- A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer PatientsR01CA214960 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2017 to 2020 · $395,140 awarded in 2020Same name and institution; not confirmed by an ID
- Palliative Therapies for Refractory Delirium in Advanced CancerR21NR016736 · NINR · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2017 to 2018 · $207,611 awarded in 2018Grant number is on one of their registry trials
- Adjuvant Lorazepam for Agitated Delirium in the Palliative Care UnitR21CA186000 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2015 to 2016 · $181,864 awarded in 2016Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Bridge to Better End-of-Life Care for Patients with Cancer: Connecting Healthcare Chaplains with Spiritual Care Providers in Faith CommunitiesR01NR021159 · NINR · WEILL MEDICAL COLL OF CORNELL UNIV · PI ALAN BENNETT ASTROW, Paul K Maciejewski, Holly Gwen Prigerson · fiscal years 2024 to 2025Named on NCT07408310
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:45 UTC. The ranking covers the 200 most relevant of 87 PubMed records, and a shared surname and initials can bring in a namesake. All 87 on PubMed
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.N Engl J Med · 20201,002 citationsRCR 47.5
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.N Engl J Med · 2017618 citationsRCR 21.4
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.J Clin Virol · 2004444 citationsRCR 8.9
- Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.Am J Respir Crit Care Med · 2004308 citationsRCR 8.5
- Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.Clin Microbiol Infect · 2004263 citationsRCR 5.3
- 258 citationsRCR 5.6
- Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.J Clin Oncol · 2013245 citationsRCR 8.7
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study.Lancet Oncol · 2014175 citationsRCR 4.7
- Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial.J Clin Oncol · 2013155 citationsRCR 6.2
- 143 citationsRCR 6.8